Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus.

J Rheumatol

From the University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; D. Ibañez, MSc, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; J. Su, MB, BSc University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; D.D. Gladman, MD, FRCPC, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital.

Published: May 2016

Objective: The traditional Framingham Risk Factor Score (FRS) underestimates the risk for coronary artery disease (CAD) in patients with systemic lupus erythematosus (SLE). We aimed to determine whether an adjustment to the FRS would more accurately reflect the higher prevalence of CAD among patients with SLE.

Methods: Patients with SLE without a previous history of CAD or diabetes followed regularly at the University of Toronto Lupus Clinic were included. A modified FRS (mFRS) was calculated by multiplying the items by 1.5, 2, 3, or 4. In the first part of the study, using one-third of all eligible patients, we evaluated the sensitivity and specificity of the FRS and the different multipliers for the mFRS. In the second part of the study, using the remaining 2/3 of the eligible patients, we compared the predictive ability of the FRS to the mFRS. In the third part of the study, we assessed the prediction for CAD in a time-dependent analysis of the FRS and mFRS.

Results: There were 905 women (89.3%) with a total of 95 CAD events included. In part 1, we determined that a multiplier of 2 provided the best combination of sensitivity and specificity. In part 2, 2.4% of the patients were classified as moderate/high risk based on the classic FRS and 17.3% using the 2FRS (the FRS with a multiplier of 2). In part 3, a time-dependent covariate analysis for the prediction of the first CAD event revealed an HR of 3.22 (p = 0.07) for the classic FRS and 4.37 (p < 0.0001) for the 2FRS.

Conclusion: An mFRS in which each item is multiplied by 2 more accurately predicts CAD in patients with SLE.

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.150983DOI Listing

Publication Analysis

Top Keywords

cad patients
12
frs
9
framingham risk
8
risk factor
8
factor score
8
systemic lupus
8
lupus erythematosus
8
patients sle
8
frs mfrs
8
eligible patients
8

Similar Publications

3D-Printed Ultra-Thin Non-Prep Lithium Disilicate Veneers: A Proof-of-Concept Clinical Case.

J Esthet Restor Dent

January 2025

Department of Prosthodontics, Geriatric Dentistry and Craniomandibular Disorders, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Objective: To test the clinical application of LCM-printed lithium disilicate veneers.

Clinical Considerations: A female patient with tooth wear was scanned with intraoral scanner (Prime Scan, Dentsply Sirona). The six non-prep veneers were designed (DentalCAD, Exocad) and printed from lithium disilicate with an LCM-printer with the thickness of 0.

View Article and Find Full Text PDF

A Prospective Randomized Trial Comparing 2 Different Paclitaxel-Coated Balloons in De Novo Coronary Artery Disease.

JACC Asia

January 2025

Division of Cardiology, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University, College of Medicine, Cheongju, South Korea.

Background: The Genoss paclitaxel-coated balloon (PCB) is a novel PCB with shellac and vitamin E as excipients, enhancing drug delivery to the target lesion and minimizing restenosis.

Objectives: This study aimed to compare quantitative coronary angiographic outcomes at 6 months after treatment of de novo coronary artery disease (CAD) with 2 different types of PCBs.

Methods: This prospective, multicenter, noninferiority trial randomized 204 patients with chronic coronary syndrome or stabilized acute coronary syndrome to treatment with the shellac and vitamin E-based PCB or the reference PCB (SeQuent Please NEO) in a 1:1 ratio.

View Article and Find Full Text PDF

Quality and content assessment of internet information on nasoalveolar molding.

BMC Public Health

January 2025

Faculty of Dentistry, Department of Orthodontics, Yeditepe University, Bagdat cad. No. 238 Goztepe, Istanbul, 34728, Turkey.

Background: To evaluate the quality and content of websites related to nasoalveolar molding (NAM).

Methods: A systematic Internet search was conducted using the keywords "nasoalveolar molding" and "presurgical nasoalveolar molding" determined through Google Trends and popular search engines: GoogleTM, YAHOO! and Yandex. The top 50 websites were evaluated for each keyword and search engine.

View Article and Find Full Text PDF

Stress Cardiac Magnetic Resonance Imaging in Intermediate-Risk Emergency Department Patients with Abnormal High-Sensitivity Troponin.

J Cardiovasc Magn Reson

January 2025

Duke University School of Medicine, Department of Medicine, 2301 Erwin Road, Durham, NC 27710 Durham, NC; Duke University Cardiovascular Magnetic Resonance Center, 2301 Erwin Road, Durham, NC 27710 Durham, NC. Electronic address:

Background: Patients presenting to the emergency department (ED) with chest pain often have abnormal high-sensitivity troponin (hsTn). However, only about 5% have an acute coronary syndrome. We aimed to assess the safety, feasibility and utility of a clinical disposition protocol including outpatient observation with stress cardiac-magnetic-resonance (CMR) in intermediate-risk patients with abnormal hsTn of unclear etiology.

View Article and Find Full Text PDF

Standard enhancement settings used on endoscopy systems significantly impair performance of artificial intelligence systems in endoscopy.

Endoscopy

January 2025

Gastroenterology and Hepatology, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam UMC Location VUmc, Amsterdam, Netherlands.

Background AI-systems in endoscopy are predominantly developed and tested using high-quality imagery from expert centers. Their performance may be different when applied on heterogeneous imagery in clinical practice. This is partially caused by the diversity in post-processing enhancement settings used in endoscopy units.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!